Bronchiectasis is characterised by an abnormal and permanent dilatation of part of the bronchial tree that causes a build-up of catarrh and the frequent development of bronchitis and pneumonia.

What are bronchiectasis

The bronchi are those ‘tubes’ that conduct air into the lungs.

Normally, the bronchi have a standard diameter, but when this increases in width, the bronchi dilate and so-called bronchiectasis develops.

These dilations of the bronchi, therefore, cause a clinical syndrome characterised by an accumulation of catarrh, which is expelled by patients almost every day, with coughing and frequent episodes of bronchitis or pneumonia.

The key to the pathology, in short, lies in the coexistence of a clinical syndrome of phlegm production, coughing, frequent infections and a permanent abnormal dilatation of part of the bronchial tree.

The alarm bells

Coughing, expulsion of phlegm and infections are the symptoms that affect most patients affected by this disease.

However, other manifestations must also be mentioned, such as the presence of blood in the sputum (haemoptysis or haemoptysis), but also shortness of breath, continuous tiredness, night sweats and fever.

These symptoms are defined as ‘accessory’, secondary therefore to the daily production of phlegm, coughing and frequent infections.

However, they must be taken into account because they often occur in association with these three main symptoms.

CT scan of the chest: the tool for diagnosis

Diagnosis first involves a high-resolution CT scan of the chest, which is now the standard for detecting the presence of bronchiectasis.

Patients, therefore, come to the attention of the pulmonologist during a pulmonology examination either because bronchiectasis has been identified during a CT scan of the chest performed for other investigations, or because they present a specific symptomatology.

In the latter case, the pulmonologist will directly request a high-resolution CT scan of the chest to diagnose the disease and assess whether the bronchiectases are clinically significant.

Congenital or acquired: the causes of bronchiectasis

Bronchiectasis can have several causes that are distinguished into congenital or acquired.

There are in fact certain genetic or systemic diseases that can lead to the development of bronchiectasis in the lung, such as cystic fibrosis, primitive ciliary dyskinesia, a pathology that affects the cilia of the bronchi, or the deficiency of a protein called alpha 1 antitrypsin.

Immunodeficiencies, whether primary or secondary, can in fact lead to the establishment of a vicious circle of recurrent infections that, in turn, lead to an anatomical alteration of the bronchus, which is prone to enlargement.

There are also a number of other associations, for example with Crohn’s disease, ulcerative colitis, rheumatoid arthritis or other connective or autoimmune disorders.

And again bronchiectasis in the context of other chronic respiratory diseases such as asthma or chronic obstructive pulmonary disease.

However, one fact should be noted: today, despite the diagnostic technologies available, approximately 40-50% of patients have idiopathic bronchiectasis, i.e., for which no cause can be identified.

In the diagnostic work-up, however, it remains of great importance to carefully assess all possible causes, as many of these are treatable and may require multidisciplinary management or referral to referral centres.

How bronchiectasis is treated

The multiplicity of causes makes the clinical and radiological manifestation of the disease very heterogeneous.

The response to the various treatments, therefore, must also be so. The specialist’s task is to identify what are called ‘treatable disease traits’ in the patient.

The first among these is mucus production: the more phlegm the patient is able to expel, the more the risk of lung inflammation and chronic infection is reduced.

Respiratory physiotherapy is therefore the most important treatment of this disease: for this reason, in the multidisciplinary team of specialists taking care of the patient with bronchiectasis, the respiratory physiotherapist is of great importance, in addition to the pulmonologist.

Other treatable traits are inherent to infection management: antibiotics are used to try to eradicate pathogens from the patient’s bronchiectasis or to try to keep chronic infections under control.

In this case, antibiotics are used by the patient by nebulisation, i.e. by aerosol, for weeks, months or even years depending on the severity of the pathology.

But anti-inflammatory interventions and interventions with immunomodulating drugs such as macrolides may also prove necessary.

Bronchodilators are then used in the event of shortness of breath or obstruction.

Finally, it is important to manage complications, from blood in the sputum to frequent bronchitis.

Multidisciplinary approach: fundamental to the treatment of the disease

The multidisciplinary approach in the management of bronchiectasis is of great importance: the multiplicity of causes and manifestations, in fact, entails the need for collaboration between different specialists.

In addition to the pulmonologist and the respiratory physiotherapist, the microbiologist, who identifies the possible presence of bacteria, fungi or non-tuberculous mycobacteria in order to continue treatment with a specific treatment; the radiologist, who takes over both at the diagnosis stage and in evaluations linked to the presence of blood in the sputum; or the otorhinolaryngologist, because chronic sinusitis is a very frequent comorbidity in patients with bronchiectasis.

The presence of the gastroenterologist is also important, whether in the presence of Crohn’s disease or ulcerative colitis, or comorbidities such as gastro-oesophageal reflux.

Read Also:

Emergency Live Even More…Live: Download The New Free App Of Your Newspaper For IOS And Android

Bronchiectasis: How To Recognise And Treat It

Pulmonary Vasculitis: What It Is, Causes And Symptoms

Bronchiolitis: Symptoms, Diagnosis, Treatment

Chest Pain In Children: How To Assess It, What Causes It

Bronchoscopy: Ambu Set New Standards For Single-Use Endoscope

Acute Bronchitis: What Are The Symptoms, How Long Does The Cough Last And How To Treat It

Blind Insertion Airway Devices (BIAD’s)

Oxygen-Ozone Therapy: For Which Pathologies Is It Indicated?

Hyperbaric Oxygen In The Wound Healing Process

Venous Thrombosis: From Symptoms To New Drugs

What Are Bronchiectasis? An Overview

Nasal Cannula For Oxygen Therapy: What It Is, How It Is Made, When To Use It

Pulmonary Emphysema: What It Is And How To Treat It. The Role Of Smoking And The Importance Of Quitting

Pulmonary Emphysema: Causes, Symptoms, Diagnosis, Tests, Treatment

Extrinsic, Intrinsic, Occupational, Stable Bronchial Asthma: Causes, Symptoms, Treatment

A Guide To Chronic Obstructive Pulmonary Disease COPD

Source:

Humanitas



Source link

AirPhysio is an effective lung expansion and mucus clearance OPEP device that utilizes OPEP (Oscillating Positive Expiratory Pressure), an all-natural process. This device assists a person’s natural cleaning procedure. Additionally, it assists in maintaining optimal hygiene in people’s lungs and restores their lung capability. AirPhysio is hugely helpful in treating many respiratory conditions, such as COPD, bronchiectasis, cystic fibrosis, etc. When people suffer from these conditions, they obstruct the capability of their bodies to clear the dirtied mucus. Additionally, their lung capacity gets lessened by 5 to 25 milliliters per year for asthmatics, and it becomes 33 milliliters per year for those who smoke. It gives rise to breathlessness after people take a light jog or climb stairs.

The capacity of the lungs and AirPhysio

Besides doing regular exercises, people can increase their lung capacity when they utilize a drug-free and all-natural process known as OPEP. AirPhysio device works as an efficient airway physiotherapy device that utilizes the process of OPEP for opening semi-closed and closed airways. It puts positive expiratory pressure to improve airway clearance via airway vibrations. A person can feel this device immediately as people blow into this device.

The versions of AirPhysio

AirPhysio is found in three distinct versions for accommodating various lung conditions and capacities, and they are:

  • AirPhysio Children – AirPhysio children are ideal for children as well as people who have a lower lung capacity variation. It is also perfect for people who require airway physiotherapy to clear mucus. Hence, it helps in improving people’s lung capability and clears every kind of obstruction.
  • AirPhysio Sports – AirPhysio sports is ideal for individuals who have healthy lungs and require opening up their airways besides providing their airways a superb clean out before an event or a workout.
  • AirPhysio CleanMyLungs – This is perfect for individuals who have got average lung capability and require airway physiotherapy for clearing mucus. It also improves the lung capacity of people before their situation worsens.

People use AirPhysio to increase their lung capability, lessen breathlessness at the time when they exercise, fasten up their recovery times, and enhance exercise tolerance after training or they have worked out. AirPhysio also helps people in clearing the airways for people who suffer from various issues, such as asthma, cystic fibrosis, COPDs (Chronic Obstructive Pulmonary Diseases), atelectasis, bronchiectasis, and various conditions that create retained secretions.

The specifications of AirPhysio

People find AirPhysio to be a groundbreaking breathing device that forms smooth pulses of positive pressure in their airways and lungs. AirPhysio is also regarded as a patented device that has a straightforward design that utilizes simple physics to create positive pressure in people’s airways and lungs. As AirPhysio is patented, it has been verified for having an exclusive design in comparison to different other OPEP systems that are available today.

Some core elements of AirPhysio are:

  • Steel ball.
  • Protective cover.
  • Circular cone.

The on-the-go design of AirPhysio turns it easier for people to carry it wherever they go. The remarkable thing is this device doesn’t comprise any chemical substances or medicine. Hence, even people who tend to be sensitive to some chemicals can use AirPhysio to keep botheration at bay. Again, people are not required to recharge or refill it, similar to other devices they use regularly. When people use AirPhysio, they can see the results within a couple of or three minutes. According to the manufacturers of this device, it is of high quality and safety. Several medical studies had affirmed the results of this device before it was made available to people in general. Every person can use AirPhysio easily, even when he does not have any earlier knowledge or skills.

How can a person use AirPhysio?

When you decide to use AirPhysio, you need to follow some simple steps:

  • 1st step – The very first thing you must do is uncap your AirPhysio because it has a shape similar to a common inhaler, and it weighs less than a regular inhaler.
  • 2nd step – You must take a deep breath and hold this device for only 2-3 seconds.
  • 3rd step – Blow the AirPhysio device for nearly 3-5 seconds until your lungs become empty of air.

So, when you complete the above-mentioned procedure, you will be able to use AirPhysio effectively.

Benefits of using AirPhysio

There are several benefits of using AirPhysio, and they outweigh the advantages of traditional and customary treatments that are used to treat breathing issues. AirPhysio is considered the highest quality and most effective product that people can use to escape from snoring and breathing troubles. Some notable benefits of using AirPhysio are:

  • AirPhysio helps in clearing people’s lungs and airways using a very simple method.
  • This device does not contain chemical substances or medicines.
  • AirPhysio doesn’t cause people any hypersensitivity reactions.
  • People can get quick results in just 2-3 minutes.
  • AirPhysio is ideal for every person.
  • Prevents and lessens the chances of suffering from pulmonary diseases. So, AirPhysio lessens some life-threatening conditions.
  • AirPhysio can be used easily.
  • AirPhysio has been prepared in an FDA-sanctioned facility.
  • When people begin to use AirPhysio, they are not required to pay frequent visits to physicians.
  • Using this device, people can save themselves from expensive medicines to lessen their breathing troubles.
  • AirPhysio is found with a risk-free and 30-day money-back assurance.

The most remarkable advantage of AirPhysio is that people do not report complaints against it. Hence, everyone can use it without hesitating. Even pulmonologists suggest the use of AirPhysio for all kinds of disease conditions having breathing difficulties.

Conclusion

AirPhysio is devoid of toxic or chemical substances. Again, it doesn’t contain any medicine either. Hence, this device is regarded as harmless for every person. Every person can use it anywhere without confronting any issues or support. If a person does not become happy using it, he can ask for 100 percent cashback along with a money-back guarantee. All these things prove that AirPhysio is nothing but a legitimate product that users can rely on. If you visit the official website of AirPhysio, you will find more than 250,000 people describing it as life-changing.

So Don’t wait, Click here to Purchase AirPhysio today!

m



Source link

Breath is essential to life, and our lungs make it happen. These two spongy organs rest deep in either side of our chest. Every time we inhale, our lungs harvest oxygen from the air we breathe and deposit it into our blood, which carries it into each cell in our body. Meanwhile, our cells constantly release carbon dioxide, which is also carried by our blood, and exhaled out through our lungs.

This incredibly complex yet undeniably critical mechanism is virtually effortless. The incessant inhalation and exhalation of our breath carries on night and day, whether we think about it or not.

The exchange of gasses our lungs perform is so vital to our wellbeing, that breathing is an automatic, built-in function of our bodies. And yet, it’s also vulnerable to breakdown by the lifestyle we lead.

Some habits clearly compromise our breathing, such as cigarette smoking. But much less is said about how our breathing suffers when we don’t move enough.

The less you move, the weaker and more compromised your lungs may become. Decades of research shows that sedentary behavior is linked to a rising risk of respiratory disease.

Fat and Breath

First, consider the fat factor. Sedentary behavior contributes to obesity, which in turn contributes to breathing problems. This direction of research began with longitudinal studies showing that, both in adults and children, there is a correlation between obesity and asthma, particularly in women.

Later, epidemiological studies confirmed this pattern, showing that a propensity for obesity predicted a tendency toward asthma.

Obesity can impair breathing in two ways. One is that excess fat, particularly in the chest and abdomen, weighs heavily on the lungs as well as the  muscle that drives the bellows of your breath: the diaphragm.

Found just below your lungs, your diaphragm is like a flexible dome that pushes up against the bottom of your lungs. When your diaphragm  contracts, your lungs fill with air. When it relaxes, the diaphragm expands and pushes the air out of your lungs.

But a diaphragm in an obese body has a larger load to carry. It has to expend more energy because it must work against the burden of excess fat. This burden can reduce lung volume as well, which means you get less out of each breath you take.

The other drawback to excess abdominal fat is that it tends to be highly inflammatory, increasing the cytokines and immune cells known to drive all forms of chronic disease.

This inflammatory factor raises the risk of lung problems such as asthma and chronic obstructive pulmonary disease (COPD), and can even shorten your life. Data from a 2012 study in the American Journal of Clinical Nutrition suggest that excessive abdominal fat contributes to the increase of an inflammatory marker known as plasma IL-6. This marker was shown to be “strongly associated with all-cause and cause-specific mortality in older persons with obstructive lung disease.”

It’s a vicious cycle, because breathing problems can also drive obesity. If you already struggle to breathe, you may be less likely to engage in strenuous physical activities that make you huff and puff. A British study found that almost 80 percent of teenagers report that the worst thing about asthma was not being able to participate in sports due to compromised breathing.

Of course, not moving enough is not the only cause for breathing problems. And not everyone with asthma is obese. However, the relationship these two diseases share is nevertheless remarkable. A meta-analysis examining over 300,000 adults found obesity and asthma were related, and the risk of asthma increased with a greater body mass index (BMI). According to some estimates, about 250,000 new cases of asthma per year in the United States are related to obesity.

If excess fat impairs breathing, losing fat improves it, regardless of the fat reduction method. One review of studies examining weight loss and asthma found that all research observed an improvement in breathing outcome when subjects slimmed down, whether the fat was removed surgically or through good old fashioned diet and exercise.

Moving for Breath

In addition to shedding the pounds that may compress your lungs and diaphragm, exercise also contributes other breathing benefits.

When you physically exert yourself, your muscles demand more oxygen, and release more carbon dioxide in the process. This means your lungs have to work harder to keep up. This improves your oxygen intake, and makes your lungs progressively stronger.

According to fitness expert Gerry Bernstone, stronger muscles make breathing easier.

“Exercise has also been shown to help to increase the size of the airways, making it easier for air to move in and out. Additionally, exercise can help to improve the elasticity of the lungs, making them more efficient at exchanging oxygen and carbon dioxide,” Bernstone said.

So how should you move if you hope to breathe better? Aerobic exercise is the form best known for its improvements to lung function, because it challenges our breathing by its very nature. With consistent aerobic practice of walking, jogging, or bicycling, improvements are easy to see. A pace and distance that would have winded you weeks or months before may become a piece of cake, forcing you to pick up the pace to make further progress.

Aerobic exercise is certainly important for improving lung health. However, other forms of exercise can play a role.

For people who suffer from asthma, COPD, cystic fibrosis, or lung cancer, the American Lung Association recommends a program called pulmonary rehabilitation. The program includes a combination of aerobics, stretching, and resistance training as part of its instruction. Stretching provides relaxation, and a chance to focus on your breath. Resistance exercises (like weight lifting) can make your muscles stronger, including the ones that work your lungs.

This predominantly exercise-focused lung improvement program may also include nutritional and psychological counseling. Doctors prescribe the program, which can be tailored for each individual. An evaluation includes a stress test to measure things like blood pressure, heart rate, and oxygen level, as well as a test to see how far you can walk in six minutes. Patients are retested months later to monitor progress.

The program also teaches the mechanics of breathing so patients have a better understanding of their condition and how to manage it. The goal is to learn how to become more active with less shortness of breath.

But you need not be diagnosed with a breathing problem to find an excuse to improve your lungs. Cross country and swim coach turned personal trainer Bonnie Frankel (78) also recommends a combination of aerobics, resistance training, and stretching, as well deep breathing exercises to further enhance your lung capacity.

Frankel says to start gradually if you’re new to exercise, but be sure to find moves that you enjoy performing, because you’re more likely to be consistent if you’re having fun. Regularity is key, but you also don’t want to overwhelm yourself  or cause an injury. To avoid becoming too easy or routine, try to mix it up.

“Your exercise program should vary in your workouts. This includes time, pace, place, mediums, and rest day or days,” Frankel said. The more you move, the quality of your life will improve.”

 

 

Conan Milner

Follow

Conan Milner is a health reporter for the Epoch Times. He graduated from Wayne State University with a Bachelor of Fine Arts and is a member of the American Herbalist Guild.

Source link

Respiratory Syncytial Virus (RSV) is on the rise in Ohio, in line with national trends in RSV cases. The Centers for Disease Control and Prevention (CDC) issued a health advisory on Friday, Nov. 4, about early, elevated respiratory illnesses, especially among children. Co-circulation of RSV, the flu and COVID-19 could place stress on healthcare systems this fall and winter, according to CDC.

In addition to COVID-19, CDC is tracking levels of RSV, influenza, and rhinovirus/enterovirus (RV/EV) that are higher than usual for this time of year, especially among children, though RV/EV levels may have plateaued in recent weeks.

The CDC recommends vaccination against flu and COVID-19 for people ages 6 months and older who are not up to date on vaccinations. This includes the updated COVID-19 booster that increases protection against the Omicron variant for people ages 5 years and older who received their primary vaccine series or an original booster at least two months ago.

RSV

The timing of RSV in a community may vary from year to year, although we typically see increases in RSV during the fall and winter months. This year, cases seem to be rising earlier than is typical. Annually, in the United States, RSV leads to about 58,000 hospitalizations, with 100-500 deaths among children younger than 5 years old and 177,000 hospitalizations with 14,000 deaths among adults aged 65 years or older. (Source: CDC Health Alert Network (HAN) 00443)

 RSV is a common respiratory virus that usually causes cold-like symptoms. It is the most common cause of bronchiolitis and viral pneumonia in infants under 1 year old and can cause severe illness in older adults. RSV is spread through respiratory droplets when someone coughs or sneezes. These droplets can settle in the eyes, nose, or mouth of another person and may settle on common household items such as tables, doorknobs, and cell phones and tablets. You can get sick by touching these surfaces, then touching your eyes, nose, or mouth before washing your hands. If you are sick with RSV, you can easily pass it to babies by snuggling them.  

Babies, young children, and older adults with chronic medical conditions such as cystic fibrosis, congenital heart disease, chronic lung disease, transplant recipients, those receiving chemotherapy, or with weakened or compromised immune systems are at risk of severe disease from RSV infection. In some cases, RSV infection can lead to worsening of chronic conditions like asthma, chronic obstructive pulmonary disease, and congestive heart failure.

Symptoms can change depending on age. Babies younger than 6 months old may show:

  •  Irritability.
  •  Decreased feeding.
  •  Decreased activity level.
  •  Temporary pauses in breathing (apnea).
  •  Fever.
  •  Wheezing.

Older babies and children may show:

  • Runny nose.
  • Nasal congestion.
  • Decreased appetite a few days before the cough.
  • Sneezing.
  • Fever.
  • Wheezing.

 In adults, the symptoms may mimic the common cold and include:

  • Runny nose.
  • Sore throat.
  • Cough.
  • Headache.
  • Fatigue.
  • Fever.

It’s important to stay home if you feel sick, even if it’s just the common cold. You may be unknowingly spreading RSV to others. It can be difficult to know the signs of breathing trouble in babies. The American Academy of Pediatrics offers advice to parents on signs/symptoms to watch for.

It’s possible for babies and young children to have more than one respiratory virus at one time. It’s important to see a healthcare provider if you think you or someone you’re caring for have respiratory illness. Most individuals with RSV can be diagnosed and cared for by a healthcare provider with an outpatient appointment and generally improve in 1-2 weeks. Your healthcare provider will be able to determine if a test for RSV is needed and the best course of treatment for the symptoms. Contact a healthcare provider immediately if you or someone you’re caring for have more severe symptoms such as dehydration, difficulty breathing, or decreased oxygen levels.

RSV is easily spread, but there are measures you can take to help prevent it from hitting your family.

  • For some babies who meet specific criteria for being at high risk of getting RSV, there is a preventive monoclonal antibody called Palivizumab available. Your child’s healthcare provider will discuss this option with you if your baby or child is eligible. Monoclonal antibodies will not treat or cure an existing infection and are only used to prevent RSV in eligible individuals.
  • Encourage good handwashing of adults and older children in the household for at least 20 seconds.
  • Remember to cover coughs and sneezes.
  • Avoid close contact with anyone who is sick (avoid kissing, handshakes, sharing eating or drinking utensils).
  • Clean high-touch surfaces like doorknobs, tables, cell phones, and other electronics. 
  • Older children, caregivers, and adults in the home who are sick with viruses should avoid interactions with individuals considered to be at high risk of severe RSV.
  • Limit time in potentially contagious settings such as childcare centers.
  • Decrease or eliminate exposure to environmental secondhand smoke and
  • Breastfeeding, if you can, to help reduce respiratory infections.
  • Keep an eye on RSV trends in your area and take extra precautions when needed.



Source link

CHRISTUS Mother Frances Hospital – Sulphur Springs Business News

November is both Lung Cancer and COPD Awareness Month

Are you noticing a theme? Our lungs are vital! As always, having an annual physical by your Primary Care provider is of utmost importance. If your provider decides you need further diagnostics they will be able to order testing. We have a Pulmonologist in Sulphur Springs several times a month. If you do not have a Primary Care provider, CHRISTUS Trinity Clinic has providers taking new patients at 903.885.3181. For a referral to the Pulmonologist, call CHRISTUS Trinity Clinic and request their Sulphur Springs clinic.

Pulmonary Rehabilitation

Do you need help managing your lung condition? Pulmonary rehabilitation can help. Pulmonary rehab is a program that can help you learn how to breathe easier and improve your quality of life. You can benefit from pulmonary rehab if you have:

· Emphesema

· Ashthma

· Chronic bronchitis

· Bronchiectasis

· Cystic Fibrosis

· A Neuromuscular disease (such as Multiple Sclerosis or Parkinson’s Disease)

· Lung Cancer

· History of smoking

· Post lung surgery

· Post COVID shortness of breath

Pulmonary rehab can make a difference. It is a safe, smart way to help you: decrease symptoms like being short of breath, coughing and wheezing. It can help you breathe better, get stronger, decrease stress, and reduce the risks of future lung problems and related hospital admissions. Pulmonary rehabilitation is designed to help increase strength, endurance, and overall health through exercise, education, diet, and support while decreasing patients’ shortness of breath. Ask your physician for a referral to CHRISTUS Mother Frances – Sulphur Springs’ Pulmonary Rehabilitation Program 903.439.4141

Free Student Athlete Injury Clinic Continues

CHRISTUS Orthopedics and Sports Medicine of Sulphur Springs continues to offer a FREE Saturday Athletic Injury Clinic for all student athletes, all sports included. The clinic is open every Saturday from 9am to 11am, through November 12. Student athletes from 7th grade to college age will be able to get a free exam and x-ray to determine a plan of care to treat their injury. The clinic will be held at our CHRISTUS Trinity Clinic Orthopedics, Medical Building 5, at 103B Medical Circle in Sulphur Springs. For more information about our Sports Medicine program, or Orthopedic services, please call 903.885.6688.

Bed count – 402 – CHRISTUS Mother Frances Hospital – Tyler

Bed count – 8 – CHRISTUS Mother Frances Hospital – South Tyler

Bed count – 25 – CHRISTUS Mother Frances Hospital – Jacksonville

Bed Count – 96 – CHRISTUS Mother Frances Hospital – Sulphur Springs

Bed count – 25 – CHRISTUS Mother Frances Hospital – Winnsboro

Bed count – 94 – CHRISTUS Trinity Mother Frances Rehabilitation Hospital

Bed count – 96 – CHRISTUS Trinity Mother Frances Louis and Peaches Owen Heart – Tyler

Bed count – 51 – Tyler Continue CARE Hospital at CHRISTUS Mother Frances Hospital

Contributed by Jennifer Heitman

Source link

Twice-weekly sessions of airway clearance physiotherapy over eight weeks led to clinically meaningful reductions in respiratory symptoms in people with cystic fibrosis (CF) in a small clinical trial.

These preliminary findings, based on patient-reported measures, support the need for further studies to determine the most effective airway clearance technique, as well as its optimal duration and frequency to achieve the best outcomes, the researchers noted.

The study, “Airway clearance physiotherapy and health-related quality of life in cystic fibrosis,” was published in the journal PLOS One.

Recommended Reading

music therapy

Airway clearance aims to promote mucus clearance from the lungs

CF is caused by mutations in CFTR, a gene that codes for a protein of the same name, which in the lungs is key for the production of a lubricating, watery mucus that helps keep the airways clean. The disease’s sticky and thick mucus clogs the airways, making breathing more difficult and leading to inflammation and an increased susceptibility to lung infections.

Airway clearance physiotherapy involves the use of an airway clearance technique to enhance mucus clearance, aiding breathing and reducing the risk of lung infections.

However, “there is a lack of evidence supporting the use of one particular airway clearance technique” in people with CF, the researchers wrote.

Also lacking are “data demonstrating the impact of airway clearance interventions on HRQoL [health-related quality of life] and … clear evidence for its optimal duration and frequency,” they added.

In a clinical trial (NCT01266473), a team of researchers at Oslo University Hospital, in Norway, evaluated the efficacy, safety, and patient perceptions of a novel airway clearance technique called specific cough technique (SCT) against standard forced expiration technique (FET). It enrolled six adults with CF who used both these techniques.

SCT, developed in Norway in the late 1990s, comprises one gentle cough to first localize and collect mucus, followed by two to three stronger coughs to expel it. FET, or huffing, involves taking a breath in followed by a fast breath out with an open “O”-shaped mouth, as if to fog up a mirror.

The six patients, four men and two women with a mean age of 35.3, all underwent two, roughly one-hour airway clearance physiotherapy sessions each week: one with SCT and one with FET, given in a random order. Their total 16 treatment sessions over eight weeks took place on two consecutive days, separated by 24 hours.

This type of individualized study, also known as N-of-1 trial, gives information about the best treatment for a patient, rather than working with the group average determined in a randomized and controlled trial.

Published study results showed that three of these six patients produced significantly more sputum, or lung mucus, with SCT than FET, up to 38% more. Five patients also reported that SCT was easy to use as a daily intervention, and all six considered it effective at clearing sputum.

Now, the researchers analyzed one of the trial’s pre-specified secondary goals: changes in the health-related quality of life.

HRQoL was assessed using the patient-reported CF Questionnaire-Revised (CFQ-R), particularly its respiratory symptoms domain, with responses given at study’s start compared with those given after the intervention.

Patients in study had chronic lung infections

The CFQ-R consists of 49 questions covering 12 topics, including nine on quality of life, an overall health perception scale, and three on symptoms (weight, respiratory, and digestion). Scores range from zero to 100, with higher scores indicating better HRQoL.

Half of these patients were positive for chronic lung infections caused by Pseudomonas aeruginosa and the other half by Staphylococcus aureus.

During the study, participants were asked to continue with their routine, at-home airway clearance treatment.

All used bronchodilators, or medications that ease breathing by relaxing muscles in the lungs and widening the airways, and inhaled saline solutions. Four patients were taking Pulmozyme (dornase alfa), a mucolytic or mucus-thinning agent by Genentech, while the other two used inhaled antibiotics regularly.

CFQ-R scores increased (improved) in all patients after the eight-week sessions, with gains ranging from 11 to 22.3 points, the trial found.

The respiratory symptom domain also showed a meaningful score increase, of at least four points, in five out of six patients, reflecting fewer symptoms. One patient’s scores fell, representing worsening symptoms.

“We found a clinically important change in respiratory symptoms score in the majority of the participants … an important finding with relevance to the airway clearance management of CF pulmonary disease,” the researchers wrote.

Potential links between HRQoL and other clinical outcomes, such as sputum production and lung function, were also assessed.

Researchers found that a greater amount of sputum produced (weight in grams) significantly associated with a larger increase in CFQ-R respiratory symptom scores. A similar link was seen between positive changes in FEV1, or how much air can be exhaled in one second after a deep breath, and the CFQ-R respiratory symptom score.

“The association between HRQoL and lung function may reflect the effect of increased sputum removal related to the airway clearance intervention,” the team wrote.

Overall, “the airway clearance intervention was associated with clinically meaningful changes in patient-reported symptoms on the CFQ-R in the majority of the participants,” the researchers wrote, adding that “findings warrant further investigation with regard to ACP [airway clearance physiotherapy] and its content, duration and frequency.”



Source link

Respiratory Therapy

We understand that if you are suffering from respiratory conditions travel can be exhausting – even dangerous. INTEGRIS Health is proud to offer respiratory therapy services right here in Edmond.

Patients with chronic lung conditions such as asthma, emphysema and cystic fibrosis, as well as those with other restrictive/obstructive pulmonary diseases and conditions can be treated at the Respiratory Therapy Department in Edmond.

Respiratory treatments include:

  • Oxygen therapy
  • Arterial blood sampling
  • Lung function testing
  • Pulse oximetry
  • Asthma therapy
  • Mechanical ventilation
  • Non-invasive mechanical ventilation

The INTEGRIS Health Respiratory Therapy Department has capabilities to provide a wide range of services including ventilator management, BIPAP/CPAP management, pulmonary function testing, EEG and stress testing. We also work with your physicians to deliver chest physiotherapy, oxygen therapy, nebulizers, inhalers, ABGs and on-sight.

Source link

Smiley face
CHRISTUS Mother Frances Hospital – Sulphur Springs Business News: Oct. 31, 2022

By Jennifer Heitman, Senior Market Development, CHRISTUS Mother Frances Hospital – Sulphur Springs, [email protected]

Are you noticing a theme? Our lungs are vital! As always, having an annual physical by your Primary Care Provider is of utmost importance. If your provider decides you need further diagnostics they will be able to order testing. We have a Pulmonologist in Sulphur Springs several times a month.

If you do not have a Primary Care provider, CHRISTUS Trinity Clinic has providers taking new patients at 903.885.3181.

For a referral to the Pulmonologist, call CHRISTUS Trinity Clinic and request their Sulphur Springs clinic.

Pulmonary Rehabilitation

Do you need help managing your lung condition? Pulmonary rehabilitation can help. Pulmonary rehab is a program that can help you learn how to breathe easier and improve your quality of life. You can benefit from pulmonary rehab if you have:

  • Emphysema
  • Asthma
  • Chronic bronchitis
  • Bronchiectasis
  • Cystic Fibrosis
  • A Neuromuscular disease (such as Multiple Sclerosis or Parkinson’s Disease)
  • Lung Cancer
  • History of smoking
  • Post lung surgery
  • Post COVID shortness of breath

Pulmonary rehab can make a difference. It is a safe, smart way to help you: decrease symptoms like being short of breath, coughing and wheezing. It can help you breathe better, get stronger, decrease stress, and reduce the risks of future lung problems and related hospital admissions. Pulmonary rehabilitation is designed to help increase strength, endurance, and overall health through exercise, education, diet, and support while decreasing patients’ shortness of breath.

Ask your physician for a referral to CHRISTUS Mother Frances – Sulphur Springs’ Pulmonary Rehabilitation Program 903.439.4141

Free Student Athlete Injury Clinic Continues

CHRISTUS Orthopedics and Sports Medicine of Sulphur Springs continues to offer a FREE Saturday Athletic Injury Clinic for all student athletes, all sports included. The clinic is open every Saturday from 9 a.m. to 11 a.m. through November 12. Student athletes from 7th grade to college age will be able to get a free exam and x-ray to determine a plan of care to treat their injury. The clinic will be held at our CHRISTUS Trinity Clinic Orthopedics, Medical Building 5, at 103B Medical Circle in Sulphur Springs.

For more information about our Sports Medicine program, or Orthopedic services, please call 903.885.6688.


CHRISTUS Trinity Mother Frances Health System includes CHRISTUS Mother Frances Hospitals – Tyler, South Tyler, Jacksonville, Winnsboro and Sulphur Springs, the CHRISTUS Trinity Mother Frances Louis and Peaches Owen Heart Hospital – Tyler, CHRISTUS Trinity Mother Frances Rehabilitation Hospital a partner of Encompass Health, Tyler Continue CARE Hospital at CHRISTUS Mother Frances Hospital, a long-term acute care facility, and CHRISTUS Trinity Clinic. CHRISTUS Trinity Clinic is the area’s preferred multi-specialty medical group, with more than 400 Physicians and Advanced Practice Providers representing 36 specialties in 34 locations serving Northeast Texas across 41 counties. For more information on services available through CHRISTUS Trinity Mother Frances Health System, visit christustmf.org

  • Bed count – 402 – CHRISTUS Mother Frances Hospital – Tyler
  • Bed count – 8 – CHRISTUS Mother Frances Hospital – South Tyler
  • Bed count – 25 – CHRISTUS Mother Frances Hospital – Jacksonville
  • Bed Count – 96 – CHRISTUS Mother Frances Hospital – Sulphur Springs
  • Bed count – 25 – CHRISTUS Mother Frances Hospital – Winnsboro
  • Bed count – 94 – CHRISTUS Trinity Mother Frances Rehabilitation Hospital
  • Bed count – 96 – CHRISTUS Trinity Mother Frances Louis and Peaches Owen Heart – Tyler
  • Bed count – 51 – Tyler Continue CARE Hospital at CHRISTUS Mother Frances Hospital
Smiley face



Source link

About AirPhysio

AirPhysio is a unique, handheld device that uses gentle pulses of air to help clear mucus from the lungs. It is drug-free and easy to use, making it an ideal option for people with lung conditions such as COPD, bronchitis, and asthma. AirPhysio can also be used to help prevent lung infections.

Do you suffer from shortness of breath? If so, you're not alone. In fact, according to the American Lung Association, more than 35 million Americans suffer from some form of lung disease. But there is hope. A new device called AirPhysio may help to relieve your symptoms and improve your quality of life. AirPhysio is a handheld device that uses gentle pulses of air to help clear the lungs. It is simple to use and is drug-free, making it a safe and effective option for those with lung conditions. In a recent study, AirPhysio was shown to improve the quality of life in patients with COPD. In this article, we will discuss the AirPhysio device and how it can help those with lung conditions. We will also look at the science behind the device and what the future holds for this promising new treatment.

AirPhysio is a clinically-proven device that helps clear mucus from the lungs. It is an easy-to-use, handheld device that is powered by air pressure. AirPhysio is FDA cleared and is used by patients with chronic lung conditions such as COPD, bronchiectasis, and cystic fibrosis. AirPhysio is a leading manufacturer of respiratory health products. Our products are designed to improve lung function and help people breathe easier. We offer a wide range of products, including air purifiers, Nebulizers, and chest physiotherapy devices. Our products are available online and through select retailers. Our mission is to improve the quality of life for people with respiratory conditions by providing innovative products and services. Get Airphysio Today and Get 50% Discount.

Why This Airphysio Reviews?

AirPhysio is an excellent product that helps clear the lungs and sinuses. It is easy to use and very effective. I highly recommend it to anyone suffering from respiratory problems. Airphysio is a wonderful product that has helped me immensely with my respiratory problems. It is a small, handheld device that uses a simple technique called "pulsating positive airway pressure" or PPA, to help keep the airways open and clear. The Airphysio is easy to use and very portable, making it perfect for those who suffer from respiratory problems or allergies. I highly recommend this product to anyone who is looking for an effective way to improve their breathing.

I'm not entirely sure what Airphysio is, but it seems to be some sort of breathing device. I found it a bit difficult to use at first, but once I got the hang of it, it seemed to help me breathe a bit better. Overall, I'm not sure if it's worth the price, but it's a decent product.

How Does AirPhysio Work?

AirPhysio is a device that helps clear mucus from the lungs. It is used by people with conditions such as bronchitis, COPD, and asthma. The device helps to loosen mucus so that it can be coughed up and out of the lungs. AirPhysio can be used with a nebulizer or with a mouthpiece. It is a safe and effective way to help clear mucus from the lungs.

AirPhysio is a device that uses a gentle stream of air to clear the lungs and help with breathing. The device is easy to use and portable, making it ideal for those with respiratory conditions. AirPhysio can be used to help with conditions such as asthma, bronchitis, and COPD.

What’s Inside AirPhysio Device?

AirPhysio Device is a clinically-proven device that helps improve respiratory function. It is effective for treating conditions such as bronchitis, COPD, and asthma. The device helps to break up mucus, making it easier to breathe. It is portable and easy to use, making it a convenient option for those with respiratory conditions.

What are the benefits of AirPhysio device?

There are many benefits of using AirPhysio. It can help to improve lung function, clear mucus from the lungs, and reduce inflammation. It is also a non-invasive and drug-free way to treat respiratory conditions. AirPhysio is easy to use and can be used at home or on the go.

•    AirPhysio helps to clear mucus and congestion from the lungs, making it an effective treatment for respiratory conditions like bronchitis, asthma, and COPD.

•    AirPhysio is a drug-free treatment option, making it safe for use by people of all ages.

•    AirPhysio is easy to use and can be done in the comfort of your own home.

•    AirPhysio helps to clear mucus from the lungs, making it easier to breathe.

•    It is a natural and drug-free way to relieve respiratory congestion.

•    AirPhysio can be used as often as needed and is safe for both adults and children.

•    Reduces mucus and congestion.

•    Clears the sinuses.

•    Eases breathing.

Side Effects Of AirPhysio Device

No, it's miles just breathing into the device, which does now not cause any aspect results. Only a slight tickling inside the throat might be caused, however, this is part of the frame's cleaning system as mucus is pulled out of the lungs.AirPhysio is a device that helps to clear the lungs and airways. It is said to be safe and effective, but there are some side effects that have been reported. If you are using AirPhysio for the first time, it is important to be aware of the potential side effects. These include feeling dizzy or lightheaded, shortness of breath, nausea, and headache. If you experience any of these side effects, it is important to stop using AirPhysio and consult your doctor.

Order Today: Naturally Improve Your Breathing by Airphysio

Features of the Device?

Assuming you would like an overview of the key features of AirPhysio:

AirPhysio is a device that helps clear the lungs and airways, making it ideal for those suffering from respiratory conditions such as bronchitis, COPD, and asthma. The device uses gentle pulses of air to break up mucus and phlegm, making it easier to cough up and expel. This can help to improve breathing and prevent respiratory infections. AirPhysio is portable and easy to use and can provide relief from symptoms when used as directed.

How to Use This Device?

To use AirPhysio, simply breathe in through the device for the prescribed number of breaths. The number of breaths will depend on your individual treatment plan. AirPhysio helps to remove mucus from the lungs and airways, making it easier to breathe.

AirPhysio is a device that helps to clear the lungs and airways. It is simple to use and can be used by people of all ages. Here is how to use AirPhysio:

Ø  Insert the mouthpiece into your mouth and seal your lips around it.

Ø  Breathe in deeply through your nose.

Ø  As you breathe in, the device will emit a short burst of air. This air will help to loosen any mucus in your lungs and airways.

Ø  Breathe out slowly through your mouth.

Ø  Repeat steps 2-4 until you feel your lungs and airways are clear.

What Does Science Say?

There is a great deal of scientific evidence that supports the use of AirPhysio for a variety of respiratory conditions. AirPhysio has been shown to be effective in clearing mucus from the lungs, improving airflow, and reducing inflammation. Additionally, AirPhysio is safe for use by both adults and children.

AirPhysio Price?

The cost of AirPhysio devices varies depending on the type of device and the retailer. However, on average, AirPhysio devices cost between $41 If you buy three you will get two devices free. There the cost of one will be $36.92. This price range makes AirPhysio devices affordable for most people who are looking for an effective way to improve their breathing.

•    AirPhysio devices are affordably priced and are a great value for the money.

•    AirPhysio devices are designed to last and are built to withstand heavy use.

•    AirPhysio devices are easy to use and require no special training or knowledge to operate.

•    AirPhysio devices are backed by a satisfaction guarantee, so you can be sure you're making a smart purchase.

•    AirPhysio devices are an investment in your health and well-being and can help you breathe easier and feel better overall.

AirPhysio Where To Buy

If you're looking to purchase AirPhysio, you can find it online through a variety of retailers. You can also find it in some major brick-and-mortar stores, although availability may vary. When purchasing online, be sure to read the description carefully to ensure that you're getting the correct product. AirPhysio is a handheld device that helps to clear mucus from the lungs. It is a drug-free and non-invasive way to help with respiratory conditions such as bronchitis, COPD, and asthma. MUST SEE: Try Airphysio Risk-Free and if You Don’t Love It, We’ll Fix It.

Refund Policy

The AirPhysio Refund Policy is designed to provide customers with a fair and efficient process for receiving a refund. To request a refund, customers must contact AirPhysio customer support within 30 days of their purchase. AirPhysio will then review the request and issue a refund if it is determined that the product is defective or not as described. Please note that AirPhysio does not issue refunds for products that have been used or damaged.

At AirPhysio, we stand behind our products and offer a 100% satisfaction guarantee. If you are not completely satisfied with your purchase, simply return the product within 30 days for a full refund. Please contact our Customer Care team at 1-888-247-7888 to and support team “[email protected]” a return.

Who Created?

AirPhysio was created by Dr Simon Moore, a highly experienced and qualified ENT (ear, nose, and throat) surgeon. Dr Moore designed AirPhysio to help people with conditions such as sinusitis, rhinitis, and other respiratory conditions. AirPhysio is a simple, yet effective device that uses gentle air pressure to help clear the sinuses and airways. Dr Moore is a leading expert in the field of ENT and has helped thousands of people find relief from their respiratory conditions.

Disclaimer:

AirPhysio is a medical device that is designed to help clear mucus from your lungs. It is important to note that AirPhysio is not a replacement for traditional medical care, and you should always consult your doctor before using this or any other medical device. Additionally, the use of AirPhysio may not be suitable for everyone, and you should always read the instructions carefully before use. AirPhysio is not a medical device and should not be used to replace conventional medical care. The information on this website is provided for educational and informational purposes only and is not intended as medical advice. If you have any concerns about your health, please consult a qualified healthcare professional.

Frequently Asked Questions (FAQS) 

Q: How can AirPhysio help with my respiratory conditions?


A: I have found AirPhysio to be helpful in managing my respiratory conditions. The device is easy to use and helps me to breathe more easily. The company's customer service is excellent, and I would recommend this product to anyone seeking an effective way to manage their respiratory conditions.

Q: What symptoms can be treated with AirPhysio?

A: AirPhysio is a great way to treat a variety of respiratory symptoms. It can help clear mucus from the lungs, making it easier to breathe. It is also effective for treating bronchitis and other respiratory infections. AirPhysio is a safe and easy-to-use product that can provide relief from a variety of respiratory symptoms.

Q: Does AirPhysio have any side effects For me?

A: I have used AirPhysio for a while now and have not experienced any side effects. It is a great product that has helped me immensely with my breathing issues. I have used AirPhysio for a while now and have not experienced any side effects. It has helped me clear my sinuses and breathe better. Overall, I am very happy with this product!

Q: How often does AirPhysio need to be used?

A: I have been using AirPhysio for a while now and I can say that it is a really great product. It is very easy to use and it doesn't take up much time. I would definitely recommend it to anyone who is looking for an easy and effective way to improve their breathing.

Q: What is the return policy?

A: The return policy of AirPhysio is fair and reasonable. I am satisfied with their customer service and would recommend their product to others. I'm very pleased with my AirPhysio and would highly recommend it to anyone. The return policy is very fair and straightforward, and I appreciate the company's commitment to customer satisfaction.

Q: What do I do if I had an issue with my order?

A: If you have an issue with your AirPhysio order, please contact customer service. They will be happy to help you resolve the issue. If you have an issue with your order from AirPhysio, the best thing to do is to contact customer service directly. They will be able to help you resolve the issue quickly and efficiently.

Q: How do I get started with the product?

A: We bought the AirPhysio for our son who has had trouble with his lungs since he was born. We were a little worried about using it, but the results have been amazing! After just a few treatments, his breathing has improved dramatically. We're so grateful to have found this product!

 

Source link

A newly compiled business publication at the headquarters of Persistence Market Research (PMR) has detected that the shares in the global physiotherapy equipment market is primarily consolidated among a small pool of prominent players who have a presence in several countries. Companies such as Enraf-Nonius B.V, DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, HMS Medical Systems, and BTL Industries, Inc. are the major players in the global physiotherapy equipment market. In terms of product offerings, Enraf-Nonius B.V. and BTL Industries, Inc. are ahead of the curve, offering physiotherapy equipment in over 50 countries.

Request the sample copy of report @ www.persistencemarketresearch.com/samples/3209

Strength of Supply Chain and Brand Name Determining Market Leader

In terms of international presence, Enraf-Nonius B.V is a highly reputed company as it has operations in over 100 countries. DJO Global, with a presence in over 50 countries, provides hysiotherapy equipment such as Intelect TranSport ultrasound, Intelect TENS Basic, Vectra Genysis therapy system, Vectra Genysis ultra applicator, and Intelect Legend combination. EMS Physio Ltd. is another key player in the global physiotherapy equipment market, offering products such as therapeutic ultrasound units, shortwave diathermy products, electrical stimulators, low-level laser therapy devices, and EMG equipment. Dynatronics Corporation, with presence in over 30 countries, markets electrotherapy products, thermal therapy products, therapeutic ultrasound products, and iontophoresis products.

Global Physiotherapy Equipment Market to Reach US$ 23.0 Bn by 2025

As per the projections of this report, the demand in the global physiotherapy equipment market will multiply at a CAGR of 6.9% during the forecast period of 2017 to 2022. Revenue-wise, the opportunities in the global physiotherapy equipment market is estimated to reach a valuation of US$23,750.9 mn by the end of 2022.

global physiotherapy equipment market

Based on product type, the analyst of the PMR report has segmented the physiotherapy equipment market into equipment, accessories, and others. While the equipment segment has been further sub-segmented into continuous passive motion, hydrotherapy, electric stimulation, cryotherapy, heat therapy, ultrasound, and therapeutic exercises, the accessories have been divided into orthoses and others. End user bifurcation of the market has been done into clinics, hospitals, and others. Application-wise, the market for physiotherapy equipment has been categorized into musculoskeletal, cardiovascular and pulmonary, neurology, and pediatrics. Geographically, North America has been highlighted as the region with maximum opportunities, although vastly populated emerging economies of India and China are expected to turn Asia Pacific into a highly lucrative region towards the end of the forecast period.

Prevalence of Cardiovascular and Neurological Diseases Driving Demand

While the escalating percentage of geriatrics in the world’s population is the primary driver of the market for physiotherapy equipment, recent technological advancements have also given strong impetus to the market. These advancements have exponentially improved the care that can be provided by these equipment. In addition to that, increasing prevalence of cardiovascular and neurological diseases, high incidences of sports injuries, growing awareness regarding therapeutic applications of physical therapy, and strengthening prevalence of obesity are some of the other factors augmenting the demand for physiotherapy equipment market. Physiotherapy offers a wide range of therapies for cardiovascular and neurological disorders.

For In-Depth Competitive Analysis, Buy Now @ www.persistencemarketresearch.com/checkout/3209

In cardiovascular diseases, physical therapy assists in clearing lung secretions in patients suffering from cystic fibrosis. In addition, physiotherapy is also useful in the treatment of heart attack, pulmonary disorders, and patient rehabilitation post coronary bypass surgery. In neurological disorders, also known as neurological physiotherapy, these equipment help in rehabilitation programs and improve patient’s ability to undertake daily activities. On the other hand,

Key Players :

  • Enraf-Nonius B.V.
  • DJO Global.
  • EMS Physio Ltd.
  • Dynatronics Corporation.
  • A. Algeo Limited.
  • BTL Industries, Inc.
  • HMS Medical Systems.
  • Whitehall Manufacturing.
  • PattersonCompanies, Inc.
  • Isokinetics, Inc.
  • Other.

Request For Report Customization @ www.persistencemarketresearch.com/request-customization/3209

About us:

Persistence Market Research, as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales[email protected]

Source link

Pamplona (EFE).- The Spanish Cystic Fibrosis Federation is celebrating its biennial congress in Pamplona this weekend. This is happening in the face of hopes for drugs that can “stop the disease and change your life in 70% of cases, although 30% continue treatment without this type of treatment.”

This was pointed out by the president of the Navarre Cystic Fibrosis Association, Cristina Mondragon, at the opening of the VIII Congress. This time it is called “Days of change, days of hope” and takes place at an “exciting” moment for patients.

In this regard, Minister of Health Carolina Darias spoke via videoconference to highlight the positive evolution in access to treatments for this disease over the past year. He cited a milestone in December 2021 when the drug Kaftrio was included in NHS funding for victims aged 12 and over.

Also for pediatric patients

“This meant “before and after” for a very important number of people, the opportunity to live by improving the quality of life of patients,” the minister emphasized.

To this progress, Darias deepened, adding the dosage approved last week of 37.5 milligrams of Kaftrio for children up to 30 kg. With the format for pediatric patients, public funding for all indications and presentations of this medicine is complete.

Participants in the opening of the VIII Congress on Cystic Fibrosis in Pamplona. EFE/ANFC

As for the congress, it features presentations by various experts who will focus on the challenges of living with cystic fibrosis, advances in its treatment, and recent advances in finding the ultimate cure.

To this end, various roundtables and workshops will address topics such as Minority Mutations: The Following Treatments in Development, Mental Health in Cystic Fibrosis, Breathing Physiotherapy and Exercise, Healthy Recipes, Early Access to New methods of treatment in Spain” or “Effects of new modulators in cystic fibrosis”.

In addition, there is a poster room at the congress where research staff or specialists can present their work and exchange knowledge.

Cystic fibrosis affects one in every 3,000 newborns, and there are more than twenty cases in Navarra, most of them children and young adults. It is a degenerative and chronic disease that mainly affects the respiratory and digestive systems and is a serious health problem that, in advanced cases, may require a lung transplant.

Edition: Maria Montoya

Source link

The company has partnered with Medsmart and Apollo Group to roll out the products

The company has partnered with Medsmart and Apollo Group to roll out the products

Australia-based AirPhysio launched its respiratory devices in the city on Saturday.

Former Australian cricketer Brett Lee launched the AirPhysio and Better Breathing product range at an event held here. Suneeta Reddy, managing director of Apollo Hospitals, was present on the occasion.

AirPhysio (Airway Physiotherapy for Naturally Better Breathing) has partnered with Medsmart and Apollo Group to roll out the respiratory devices in the country. Paul O’Brien, global chief executive officer of AirPhysio and Better Breathing Group, said from two countries in January 2020, AirPhysio had now expanded to over 106 countries.

According to a press release, the devices are Australian made and owned and started development in September 2015 after identifying a gap in the market and need for medication-free devices to help people improve their lung hygiene and capacity. The device uses a process similar to the cough mechanism to help to open up and expand the lungs for conditions such as atelectasis and help clean the lungs of mucus and pollutants for patients with respiratory conditions, such as asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

Mr. Lee spoke about the experience of his mother, who had breathing difficulties, in using the AirPhysio device and his experience in using the Better Breathing Sport device.

Ms. Suneeta Reddy said 65 million people around the world suffered from COPD. David Eggleston, Deputy Consul General, Consulate of Australia, Chennai, said the signing of the Australia-India Economic Cooperation and Trade Agreement in April 2022 was a significant step forward.

“The relationship we see here today between AirPhysio, Apollo Hospitals and Medsmart demonstrates the future links that we hope to see in critical areas such as healthcare,” he said. G. Narotham Reddy, managing director of Medsmart, was present.

Source link

Cystic fibrosis (CF) is an inherited illness that ravages the lungs and many other organs in the body. Fifty years ago, children with CF generally died by about age 10. But wide-ranging research has led to dramatic improvements in treatment. Today, the life expectancy for CF patients in the U.S. has risen to about 37 years. Some with CF live into their 40s, 50s, or even older.

CF affects 30,000 people in the U.S. and 70,000 worldwide. The main symptom is thick mucus that clogs the lungs and leads to repeated infections, scarring (fibrosis), and gradual deterioration.

“When we breathe, mucus is there to keep us protected, trapping particles and bacteria and moving these away from the lungs,” says Dr. William B. Guggino, a researcher with the Johns Hopkins Cystic Fibrosis Center. But in CF, “the mucus gets sticky, and bacteria grow on sticky mucus.”

Because CF also affects other organs, such as the pancreas, it interferes with the body’s ability to digest food. This is a special concern for children and youths. Breathing, growth, and development are all affected by the disease.

CF is caused by abnormal changes in a gene called CFTR. More than 10 million people in the U.S. carry an abnormal version of the gene, but most probably don’t realize it because they have no symptoms. To have CF, a person must inherit 2 defective copies of the gene—one from each parent.

Yet it’s not that simple. Some people have a relatively mild form of the disease, while others have a more severe form. NIH-funded researchers are studying what causes these differences.

One team of researchers is looking at identical twins with CF. In general, twin studies can tease apart certain factors, such as how variations in genes and environment affect survival. If both twins have CF and one fares better than the other, are certain genes affecting the way the disease is activated? If these twins live separately, do different environments affect their lungs?

Although CF has no cure, research has yielded new and effective medications. These help thin the mucus, open the airways, fight infection, and aid digestion.

A daily routine of good self-care is also essential. This often includes repeated rounds of chest physical therapy, also called chest clapping or percussion. Patients must sit or lie in a position to help drain the mucus from their lungs. Then a therapist, family member, or friend claps them rhythmically on the back to help loosen mucus so it can be coughed up. A mechanical vest can also be used to vibrate the chest and clear the airways.

Couples with a family history of CF should speak with their health care provider about newborn screening when planning or expecting a baby. “Even in infants only a few months old, the disease is often silent, and the disease quickly progresses,” says Dr. Susan Banks-Schlegel, who oversees a CF research program at NIH. “Newborn screening is very important so we can intervene early.” Early diagnosis and treatment can help raise the life expectancy of people living with CF.

 

A Breakdown in Breathing was originally published by the National Institutes of Health.”

Source link

«Misurina could become a center not only for the treatment of children’s asthma, but also for rehabilitation for young lung transplants, providing ad hoc programs with physical and sporting activity, essential for these diseases. But to do all this you need resources ».

Speaking is Dr. Ermanno Baldo, former medical director of the Pio XII Institute from June 2017 to autumn 2019. Pediatrician with a specialization in immuohematology, head physician at the Rovereto hospital, he has always dealt with respiratory diseases. Faced with the decision of the diocesan work of San Bernardo degli Uberti to close the structure at the end of this year, he is very disappointed. “It is a real shame that we are going to lose a unique institute in Italy, where at the end of the second post-war period, we began to study and understand that asthma and respiratory diseases could find a cure in high-altitude structures where the air it is clean. In Misurina », the doctor is keen to specify,« in addition to clean air, we also find a lower barometric pressure which thus allows for different breathing. I myself have noticed that one day after arrival the children are already breathing better, playing football without problems. In Misurina we have seen that in 10-15 days the allergic inflammation of the lung is resolved ».

“In Misurina we were 120 children From there the drive to become a doctor”

pda


For Baldo Misurina «it is the ideal place to develop projects not only for the treatment of asthma problems, but also as a rehabilitation place for those who have undergone a lung transplant. «For a transplant patient of this type, respiratory rehabilitation is essential to re-expand the lung. We had already begun to think about it during my direction and we had also involved the Italian association against Cystic Fibrosis in order to start a rehabilitation center there. Before the first crisis of the institute began in 2019, there were many projects in place, but then everything fell apart “, says the pediatrician who adds:” The mountain around 1700-1900 meters above sea level is a perfect environment to heal these respiratory diseases. In the mountains, an asthmatic child will be able to do things that would be impossible in the plains because the altitude and clean air, without allergens, allows for control of the disease ».

The Pio XII Center for asthmatic children in Misurina closes at the end of the year


The pediatrician specifies that a person develops his lungs up to the age of 18 “so we can change the fate of a child if we train him to breathe and to enlarge his lungs. The larger the lungs, the more he will have a good old age ».



Source link

For those who aren’t familiar, respiratory therapy is a discipline that involves caring for patients with breathing problems. They assess, diagnose, treat and manage patients with respiratory conditions, such as asthma and cystic fibrosis. Respiratory therapists also work with patients who have sleep apnea, lung cancer, and other respiratory diseases. They work in many settings, including the critical care unit of a hospital, assisting patients who are on a ventilator. Respiratory therapy is a growing field that offers the opportunity for a meaningful career where you can earn a good living. If you want to learn more, read on to find out about the benefits of a respiratory therapy degree.

What are the benefits of a respiratory therapy degree?

There are many benefits to earning a degree in respiratory therapy, but you should also consider online respiratory therapy programs. Online programs offer students the flexibility to complete their coursework on their own schedule, which is ideal for working professionals. Online degree programs also typically have accreditation from the Commission on Accreditation for Respiratory Care (CoARC), which is the gold standard in respiratory care education. While an on-campus education may be preferable for some students, there are real advantages to online learning.

Perhaps the most obvious benefit of earning your degree in respiratory therapy is that it will offer you a wealth of opportunities for career advancement. With a respiratory therapy degree, you can work in a variety of settings, including hospitals, clinics, and home health care. You can also pursue specialized roles within the field such as critical care respiratory therapist or pulmonary rehabilitation therapist. Additionally, respiratory therapy degrees are in high demand, so you are likely to find plenty of employment opportunities once you graduate.

Respiratory therapists enjoy above-average salaries and excellent job security. The median respiratory therapist’s salary is $61,830, but top earners can make significantly more. The industry is also projected to experience 14 percent job growth over the next decade, which is much faster than the average for all occupations. This is explained by the fact that our aging population is increasingly in need of respiratory care. In addition, the rise in asthma and other respiratory illnesses h.as led to a greater demand for respiratory therapists.

How can you prepare for your degree program?

Whether you choose an online program or not, you will need to have a quiet place to study when you have work to do. Pick a room in your house that is quiet and free from distractions. This could be a bedroom, home office, or even the living room. Make sure you have everything you need in your study zone, including a desk lamp, textbooks, a computer, and a notepad and pen. You could also invest in decor so you feel comfortable in the space. Plants make a perfect addition to any study spot or home office, as research has shown that can improve your mood, boost focus, and alleviate stress.

Time management is one of the most valuable skills that students can learn. One of the best ways to improve your time management skills is to create a schedule and stick to it. This means setting specific times for studying, homework, socializing, and relaxing, and then making a concerted effort to stick to that schedule. Of course, life can sometimes get in the way and you may have to adjust your schedule accordingly, but you will see improvement if you’re consistent. If there are big tasks that seem overwhelming, try breaking them down into smaller, more manageable tasks. This will make the task seem less daunting.

As you can see, becoming a respiratory therapist can be a smart and deeply fulfilling career choice. Respiratory therapists play a vital role in assisting patients who are struggling with breathing problems. They work with patients of all ages, from newborns to the elderly, and can help treat many respiratory conditions. What’s more, respiratory therapists are in high demand, and can typically find employment in a number of settings, including hospitals, clinics, and long-term care facilities. Earning your degree in respiratory therapy is more accessible than ever, you can even look into online degree programs that allow you to work from home. Follow this advice and you’ll be well on your way to a successful career as a respiratory therapist.

Source link

Use of Kaftrio (elexacaftor, tezacaftor, and ivacaftor), sold in the U.S. as Trikafta, helped a woman with cystic fibrosis (CF) more easily become pregnant and maintain her health throughout the pregnancy and child’s birth, according to a case report from France.

The woman had struggled in a previous pregnancy, due to poor fertility and repeat CF exacerbations, before starting on the triple combination treatment developed and marketed by Vertex Pharmaceuticals. Both children and the woman were discharged and went home within a month of her giving birth.

Our case shows a real benefit for the mother without detection of any adverse foetal outcomes,” the researchers wrote.

Recommended Reading

Trikafta cystic fibrosis | Cystic Fibrosis News Today | clinical trial illustration

The report “Comparison of two pregnancies with and without elexacaftor-tezacaftor-ivacaftor in a woman with cystic fibrosis” was published as a letter in the journal Respiratory Medicine and Research.

Pregnancy rates among women with CF have risen in recent years with improvements in therapeutic options. The report noted that 50 pregnancies among this patient group, resulting in 33 live births, were identified in France in 2019.

Kaftrio started eight months after first difficult pregnancy

Kaftrio, a modulator therapy, is among these options. It helps the defective CFTR (cystic fibrosis transmembrane conductance regulator) protein, the disease’s cause, work more effectively. Kaftrio was approved in France in 2020, and it was available under compassionate use to patients there with advanced CF since 2019.

Little data, however, “are currently available on the use of CFTR modulators in pregnant women, and the real impact on maternal and [fetal prognosis] during pregnancy is still unclear,” the researchers wrote.

A team at Hôpital Foch, near Paris, described two pregnancies, one before and one after starting on Kaftrio, in a woman with CF who was 32 years old at the time of the second pregnancy. The woman had two copies of the F508del mutation (the most common CF-causing CFTR gene mutation), respiratory impairment, chronic airway infection with Pseudomonas aeruginosa and methicillin-resistant S. aureus, exocrine pancreatic insufficiency, and CFTR-related diabetes.

Exact dates of care given were not included in the report.

Her first pregnancy came after seven years of infertility treatment and several in vitro fertilization cycles. During the first trimester, her treatments included pancreatin, montelukast, azithromycin, L-thyroxine, insulin therapy, daily respiratory physiotherapy, and enteral nutrition.

She gained a total of 3 kg (about 6.6 pounds) during the pregnancy. Her diabetes, with blood-sugar levels measured using the glycated hemoglobin A level test, was 6.6% before conception, consistent with a diabetes diagnosis, and 5.7% shortly before her delivery, consistent with pre-diabetes.

Her percent predicted forced expiratory volume in one second (ppFEV1), a measure of lung heath, was 50% before conception. She had three pulmonary exacerbations, a sudden worsening in respiratory symptoms, at 11, 20, and 25 weeks of gestation that were treated with antibiotics, including one intravenous treatment regimen, the scientists reported.

A fourth exacerbation seven months into her pregnancy (28 weeks gestation) required hospitalization and treatment with intravenous antibiotics, which continued until delivery, and nocturnal oxygen.

The baby was born after 33 weeks of gestation by caesarian section, necessitated by the woman’s ppFEV1 having dropped to 31%. Born weighing 2.37 kg (about 5.2 pounds) and with transitory respiratory distress syndrome, the baby was treated with continuous positive airway pressure for 27 hours. The mother and child were released to home care 22 days after delivery.

‘Positive impact’ on woman’s fertility, overall health

Eight months later, the woman started using Kaftrio — elexacaftor at 200 mg and tezacaftor at 100 mg, both taken once daily, and ivacaftor at 150 mg every 12 hours. She naturally became pregnant 20 days after starting the therapy.

This ease of pregnancy and the fertility it implied “appears as a major difference” with the first pregnancy,  the scientists wrote.

“After ethical discussion about the patient health and impact of correctors [elexacaftor and tezacaftor], we agreed that the benefits of CFTR modulators outweighed any potential unknown risk to the baby,” they added.

Other treatments remained similar to those used in the initial pregnancy, except for her no longer needing respiratory physiotherapy and enteral nutrition.

Her ppFEV1 had risen to 53% one month after starting on Kaftrio, increasing to 60% pre-delivery, and she gained 10 kg during this pregnancy. Her glycated hemoglobin A levels were a normal 5.5% in tests given before conception and delivery, indicating no diabetes.

She had one pulmonary exacerbation treated at the home with oral antibiotics, and she reported respiratory discomfort in her eighth month of pregnancy (33 weeks of gestation).

Her baby, a boy, was delivered by C-section early, at 34.5 weeks of gestation, due to ruptured membranes in the mother and an abnormal fetal heart rate. He weighed 2.86 kg and also had transitory respiratory distress syndrome that was treated for seven hours with continuous positive airway pressure. Mother and child returned home 11 days after the birth.

“Our case shows a positive impact of [Kaftrio] on fertility. It resulted in a spontaneous pregnancy shortly after beginning the treatment that may have been due to improvements in cervical mucus consistency and pH,” the researchers wrote.

Abnormal CFTR function is associated with poor fertility due to a viscous PH imbalance in cervical mucous. “The current hypothesis still to be proven is that CFTR modulators decrease viscosity and increase pH in cervical mucous secretions,” the researchers added.

They also noted the ease of fertility evident in this pregnancy may be due to the woman’s better nutritional status after starting on Kaftrio.

Kaftrio’s use here was also associated with ppFEV1 improvements and fewer and less severe pulmonary exacerbations. “The patient had never had such good results before,” the researchers wrote.

The first child is still healthy at age 18 months, the team noted, and the other is continuing to be monitored though he was “born without evidence of congenital malformation.”

In the U.S., 45 pregnancies and 29 live births were reported in 2020 among CF patients using Trikafta.

An observational study called the Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS, NCT04828382), which started in 2021, is evaluating the use of CFTR modulator therapy on lung function during pregnancy and lactation. The study is enrolling eligible women with CF at sites across the U.S., and it is estimated to finish in 2025.



Source link

From a pathophysiological point of view, bronchiectasis disease is sustained by a vicious circle in which an alteration in mucociliary clearance is followed by chronic respiratory infections, chronic inflammation, and irreversible bronchial anatomical damage, which over time can lead to a progression and aggravation of the disease itself.

 What are the causes of bronchiectasis?

Bronchiectasis can have several causes, either congenital or acquired, such as primary or secondary immune deficits, previous pneumonias, alterations in ciliary motility, fungal infections (such as from Aspergillus) or from non-tuberculous mycobacteria, autoimmune and chronic inflammatory processes.

However, in 40-50% of cases the cause of the disease remains unknown despite extensive diagnostic investigations.

What are the symptoms of bronchiectasis?

The main symptoms/signs of bronchiectasis are coughing, daily expectoration, and recurrent respiratory infections (including pneumonia).

In addition to these symptoms, episodes of haemophthisis/haemoptysis (blood in the sputum), dyspnoea (shortness of breath), persistent fever, and daily significant asthenia may also be present.

Diagnosis

The gold standard for the diagnosis of bronchiectasis is a high-resolution chest CT scan and the pulmonologist is the referral specialist.

At the time of the diagnosis of bronchiectasis and depending on the severity of the clinical picture, a series of laboratory tests should be performed, including quantitative assessment of total IgG, IgA, IgM and IgE immunoglobulins, IgG and IgE specific for A. fumigatus, protein electrophoresis, complete respiratory function tests, a sputum culture test for bacteria, fungi and mycobacteria, a visit with a respiratory physiotherapist and a pulmonologist.

Then, every six months or annually, and always depending on the severity of the clinical picture, it is recommended to perform a sputum culture examination, and a re-evaluation with a respiratory physiotherapist and a pulmonologist.

In some patients it is also important to rule out certain genetic disorders (such as cystic fibrosis or primitive ciliary dyskinesia) as well as the coexistence of possible connective tissue diseases (such as rheumatoid arthritis).

Treatments

There are to date no European or American approved drugs to treat this disease.

The management of bronchiectasis is totally individualised on the basis of the clinical and biological characteristics expressed by each patient.

The most important treatment is respiratory physiotherapy, which uses a specific exercise programme to remove the mucus that tends to stagnate in bronchiectasis.

Other important tools at our disposal are antibiotics, immunomodulatory therapies, bronchodilator drugs (if bronchial obstruction is present) as well as treatments to manage the two most frequent complications of the disease: flare-ups and the presence of blood in the sputum.

The optimal management of bronchiectasis passes through a multidisciplinary approach in which the pulmonologist, flanked by the respiratory physiotherapist, can count on the collaboration of other professionals including the clinical microbiologist, the radiologist, the clinical immunologist/rheumatologist, the geneticist, the gastroenterologist and the otorhinolaryngologist.

Read Also:

Emergency Live Even More…Live: Download The New Free App Of Your Newspaper For IOS And Android

Blind Insertion Airway Devices (BIAD’s)

Oxygen-Ozone Therapy: For Which Pathologies Is It Indicated?

Hyperbaric Oxygen In The Wound Healing Process

Venous Thrombosis: From Symptoms To New Drugs

Prehospital Intravenous Access And Fluid Resuscitation In Severe Sepsis: An Observational Cohort Study

What Is Intravenous Cannulation (IV)? The 15 Steps Of The Procedure

Nasal Cannula For Oxygen Therapy: What It Is, How It Is Made, When To Use It

Pulmonary Emphysema: What It Is And How To Treat It. The Role Of Smoking And The Importance Of Quitting

Pulmonary Emphysema: Causes, Symptoms, Diagnosis, Tests, Treatment

Extrinsic, Intrinsic, Occupational, Stable Bronchial Asthma: Causes, Symptoms, Treatment

A Guide To Chronic Obstructive Pulmonary Disease COPD

Source:

Humanitas



Source link

Mucus in the lungs is common in certain health conditions and needs treatment. For example, if you have bronchiectasis or chronic obstructive pulmonary disease (COPD), clearing mucus from your lungs is an important part of managing your lung disease.

Having too much mucus in your lungs or phlegm build-up can block narrowed air passages and make it hard for you to breathe. Increased mucus in the lungs can also lead to infections, such as pneumonia.

There are ways to treat mucus in the lungs, including controlled coughing, medications, and chest physiotherapy.

This article will go over some causes of mucus in the lungs as well as ways that your provider might want you to clear mucus from your lungs as part of your treatment.

Verywell / Emily Roberts

Home Remedies and Lifestyle Changes for Mucus in Lungs

You can use at-home exercises to help prevent and decrease mucus buildup in your lungs. If you have lung disease these techniques should be used regularly to loosen and remove the excess mucus from your lungs.

Controlled Coughing for Mucus in Lungs

Controlled coughing engages the chest and stomach muscles to clear mucus in the lungs. Unlike a hacking cough that uses the chest muscles more than the diaphragm, controlled coughing focuses on stabilizing the core muscles to engage the diaphragm more effectively.

There are two common methods of controlled coughing: deep and huff.

How to use deep coughing to clear mucus in the lungs:

  1. Sit comfortably in a chair with your feet on the ground.
  2. Wrap your arms around your stomach, and take a deep breath in.
  3. Keeping your lips pursed, cough forcefully while pressing your arms firmly against your stomach muscles.

How to use huff coughing to clear mucus in the lungs:

  1. Take a deep, slow breath to fully expand your lungs.
  2. Tense your stomach muscles
  3. Exhale three times very quickly and make a "ha" sound with each breath.
  4. Repeat this step, keeping your core firm, until you feel the mucus in your lungs breaking up.
  5. Cough deeply to clear your lungs.

Deep Breathing for Mucus in Lungs

When you do deep breathing exercises, you slowly breathe in (inhale) and breathe out (exhale) to help your lungs expand. These breathing exercises are examples of pulmonary hygiene—treatments that use physical manipulation techniques to help you cough up sticky mucus and clear your lungs.

Your respiratory therapist can teach you deep breathing techniques that you can do at home on a regular schedule to help keep your lungs clear.

Over-the-Counter (OTC) Treatment for Lung Mucus

Several OTC medications can help clear excess mucus from your lungs, for example, Robitussin and Mucinex.

These medications are expectorants. They have an ingredient called guaifenesin in them that thins and loosens mucus in the lungs to make it easier to cough up. They can also block the production of the main protein in mucus (mucins).

Most expectorants can be bought at a pharmacy or grocery store, but some combination drugs that have expectorants and other ingredients in them require a healthcare provider's prescription.

Prescription Medications for Lung Mucus

Mucolytics, including N-acetylcysteine and carbocysteine, are only available by prescription.

These medications work differently than expectorants. Mucolytics break the chemical bonds in mucus to help make it easier to cough up.

Chest Physiotherapy for Mucus in Lungs

Chest physiotherapy (CPT) techniques can be done manually or with a mechanical device. A CPT routine can take anywhere from 20 minutes to an hour.

You can do some CPT techniques by yourself, but others require help from a partner, such as a therapist or a family member at home.

  • Manual CPT combines chest percussion and vibration to loosen the mucus in the lungs and make you cough. To do chest percussion, a therapist or loved one will clap on your chest or back to help loosen the thick mucus in your lungs so you can cough it up. Vibration is done by placing their flat hands on your chest wall and making a shaking motion.
  • Airway clearance devices are hand-held machines that use high-frequency vibration, low-frequency sound waves, and other technology to break up mucus in the lungs. They are easy to use by yourself. Some of the devices are worn like a vest, while others require you to breathe into them (like a flute).

While you are having chest physiotherapy, make sure you breathe in and out slowly and fully until the mucus in your lungs is loose enough to cough up. Your therapist will show you how to get into a position that uses gravity to help the mucus in your lungs drain.

Alternative Medicine for Lung Mucus

There are some natural remedies that may help reduce the mucus in your lungs. Keep in mind that even though they are "natural," complementary and alternative medicine (CAM) therapies can have side effects.

CAM therapies that may help clear mucus in the lungs include:

  • Warm fluids: Drinking warm (not hot) liquids can help loosen thickened mucus. Try tea, warm broth, or hot water with lemon.
  • Steam: You can use a device such as a cool-mist humidifier or steam vaporizer to breathe in warm air. You can also take a hot shower or breathe in vapors from a pot of simmering water. These methods introduce moist air into your air passages, which helps loosen the mucus in your lungs. However, do not inhale oils because they can cause an inflammatory or allergic lung reaction.
  • HoneyHoney may reduce inflammation and coughing. However, it is not clear whether honey specifically helps in coughing up mucus.
  • Chinese medicine: Chinese herbs and treatments have traditionally been used to reduce mucus in the lungs. While there are anecdotal reports that they are helpful, the scientific data is not clear about the benefits.
  • A few herbs—including mao huang (Herba ephedrae), tao ren (Semen persicae), and Huang qin (Radix scutellariae)—may ease the symptoms of respiratory disease.
  • Qigong, a practice of breathing exercises and movements, may also help.

Ask Your Provider About CAM for Lung Mucus

CAM therapies are not safe for everyone. If you take certain medications or have certain health conditions, you may not be able to use them.

If you want to try an herb, supplement, or natural remedy to help clear mucus in your lungs, talk to your provider. They will make sure that it would be safe for you to try these treatments.

Summary

Mucus in the lungs can be part of having certain health conditions and something that you'll need to learn how to manage.

Regularly clearing mucus from your lungs is part of living with bronchiectasis and COPD. Controlled coughing, deep breathing, over-the-counter and prescription medications, chest physiotherapy, and alternative therapies help by reducing, loosening, and coughing up the mucus to prevent lung infections.

It's important that you use mucus-reducing strategies on a regular basis, not just when your symptoms act up. If you have been diagnosed with pulmonary disease, talk to your healthcare provider or respiratory therapist about the best approaches for managing mucus in your lungs.

Frequently Asked Questions

  • How do you know if your lungs are filled with mucus?

    If you have mucus in your lungs, you might have a "wet" cough or be able to hear the fluid in your chest when you breathe. You may wheeze or find it harder to breathe if there is mucus build-up in your lungs.

  • How do I naturally get rid of mucus in the lungs?

    One way to get rid of mucus or phlegm naturally is by doing controlled huff coughing to clear your lungs.

    1. Sit up straight, slightly tilt your chin toward the ceiling, and open your mouth.
    2. Slowly take a deep breath in, filling your lungs about three-quarters full.
    3. Hold your breath for three seconds.
    4. Forcefully exhale in a slow, continuous manner.
    5. Repeat steps one to four at least two or three more times. Then, perform a single strong cough. This should remove mucus concentrated in the larger airways.

  • Is chest congestion common in COVID-19?

    About one-third of people with COVID-19 have chest congestion or pressure as a symptom. COVID often causes a dry (non-productive) cough but some people have a productive cough and cough up thick mucus.

  • What causes phlegm?

    The body makes phlegm and mucus to line the tissues and protect and moisturize them, as well as trap potential irritants and germs.

  • What medicine can be used to clear phlegm from the throat?

    Mucus thinners (mucolytics) are over-the-counter (OTC) medicines that help thin mucus or phlegm in the airways, making it easier to cough up. Two types of mucus thinners are Pulmozyme (dornase alfa) and hypertonic saline.

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Poole P, Sathananthan K, Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Airways Group, ed. Cochrane Database of Systematic Reviews. 2019 May 20;5(5):CD001287. doi:10.1002/14651858.CD001287.pub6

  2. Aaron SD. Mucolytics for COPD: negotiating a slippery slope towards proof of efficacy. Eur Respir J. 2017;50(4). doi:10.1183/13993003.01465-2017

  3. Warnock L, Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst Rev. 2015;(12):CD001401. doi:10.1002/14651858.CD001401.pub3

  4. Cohen HA, Hoshen M, Gur S, Bahir A, Laks Y, Blau H. Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single-blinded, multicenter studyWorld J Pediatr. 2017;13(1):27-33. doi:10.1007/s12519-016-0048-4

  5. Tong H, Liu Y, Zhu Y, Zhang B, Hu J. The therapeutic effects of qigong in patients with chronic obstructive pulmonary disease in the stable stage: a meta-analysis. BMC Complement Altern Med. 2019;19(1):239. doi:10.1186/s12906-019-2639-9

  6. American Lung Association. Understanding Mucus in Your Lungs.

  7. Centers for Respiratory Health. Clearing lung mucus in five easy steps with huff coughing.

  8. Cystic Fibrosis Foundation. Mucus thinners.

By Deborah Leader, RN

 Deborah Leader RN, PHN, is a registered nurse and medical writer who focuses on COPD.

Source link

Abstract

Replacing traditional airway clearance therapy (tACT) with exercise (ExACT) in people with cystic fibrosis (pwCF) is a top research priority. A UK-based e-Delphi consensus was performed to inform the type(s), duration and intensity of ExACT. The expert panel comprised CF physiotherapists, doctors, pwCF and parents/partners. Exercise ACT was considered to be aerobic activity, of at least 20 min duration and intense enough to elicit deep breathing. Consensus was reached that assessment breaths, coughs and huffs should accompany exercise to remove loose secretions, with support for trials to investigate ExACT versus tACT during times of stable disease but not pulmonary exacerbations.

  • Cystic Fibrosis
  • Exercise
  • Paediatric Lung Disaese

Source link

A newly compiled business publication at the headquarters of Persistence Market Research (PMR) has detected that the shares in the global physiotherapy equipment market is primarily consolidated among a small pool of prominent players who have a presence in several countries.

Strength of Supply Chain and Brand Name Determining Market Leader

In terms of international presence, Enraf-Nonius B.V is a highly reputed company as it has operations in over 100 countries. DJO Global, with a presence in over 50 countries, provides hysiotherapy equipment such as Intelect TranSport ultrasound, Intelect TENS Basic, Vectra Genysis therapy system, Vectra Genysis ultra applicator, and Intelect Legend combination.

Want Insights To Physiotherapy Equipment Market? Ask For Sample! www.persistencemarketresearch.com/samples/3209

Company Profiles

  • Enraf-Nonius B.V.
  • DJO Global.
  • EMS Physio Ltd.
  • Dynatronics Corporation.
  • A. Algeo Limited.
  • BTL Industries, Inc.
  • HMS Medical Systems.
  • Whitehall Manufacturing.
  • PattersonCompanies, Inc.
  • Isokinetics, Inc.

Planning To Conclude Your Strategy On A Decisive Note In The Physiotherapy Equipment Market? Glance Through The “Methodology” Implied! www.persistencemarketresearch.com/methodology/3209

EMS Physio Ltd. is another key player in the global physiotherapy equipment market, offering products such as therapeutic ultrasound units, shortwave diathermy products, electrical stimulators, low-level laser therapy devices, and EMG equipment. Dynatronics Corporation, with presence in over 30 countries, markets electrotherapy products, thermal therapy products, therapeutic ultrasound products, and iontophoresis products.

Global Physiotherapy Equipment Market to Reach US$ 23.0 Bn by 2025

As per the projections of this report, the demand in the global physiotherapy equipment market will multiply at a CAGR of 6.9% during the forecast period of 2017 to 2022. Revenue-wise, the opportunities in the global physiotherapy equipment market is estimated to reach US$23,750.9 mn by the end of 2022.

Based on product type, the analyst of the PMR report has segmented the physiotherapy equipment market into equipment, accessories, and others. While the equipment segment has been further sub-segmented into continuous passive motion, hydrotherapy, electric stimulation, cryotherapy, heat therapy, ultrasound, and therapeutic exercises, the accessories have been divided into orthoses and others.

End user bifurcation of the market has been done into clinics, hospitals, and others. Application-wise, the market for physiotherapy equipment has been categorized into musculoskeletal, cardiovascular and pulmonary, neurology, and pediatrics.

Geographically, North America has been highlighted as the region with maximum opportunities, although vastly populated emerging economies of India and China are expected to turn Asia Pacific into a highly lucrative region towards the end of the forecast period.

Nevertheless, the vendors operating in the physiotherapy equipment market are expected to gain new opportunities in vastly populated emerging economies of India and China as well as recent technological advancements such as exoskeletons, virtual reality, robotics, interactive video games, and implanted devices.

How About Knowing The Product/Technology Driving The Physiotherapy Equipment Market Before Investing Therein? Click The “Purchase Now” Button Of Our Physiotherapy Equipment Market Report! www.persistencemarketresearch.com/checkout/3209

Prevalence of Cardiovascular and Neurological Diseases Driving Demand

While the escalating percentage of geriatrics in the world’s population is the primary driver of the market for physiotherapy equipment, recent technological advancements have also given strong impetus to the market. These advancements have exponentially improved the care that can be provided by these equipment.

In addition to that, increasing prevalence of cardiovascular and neurological diseases, high incidences of sports injuries, growing awareness regarding therapeutic applications of physical therapy, and strengthening prevalence of obesity are some of the other factors augmenting the demand for physiotherapy equipment market. Physiotherapy offers a wide range of therapies for cardiovascular and neurological disorders.

In cardiovascular diseases, physical therapy assists in clearing lung secretions in patients suffering from cystic fibrosis. In addition, physiotherapy is also useful in the treatment of heart attack, pulmonary disorders, and patient rehabilitation post coronary bypass surgery. In neurological disorders, also known as neurological physiotherapy, these equipment help in rehabilitation programs and improve patient’s ability to undertake daily activities. On the other hand,

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – www.persistencemarketresearch.com

Source link